Devon Applegate, PhD

Postdoc @ Cornell studying psychedelics
Alumni of The Ohio State University & Binghamton University #firstgen #gobrowns

[Devon Applegate, PhD @devon_applegate]

@SportsBoyTony Go to a backers bar tomorrow. I’ll also be in town, the people would love it.

[Devon Applegate, PhD @devon_applegate]

@OhioTate Uncle Steve knows ball!

[Devon Applegate, PhD @devon_applegate]

@SportsBoyTony Bro 😂😂

[Devon Applegate, PhD @devon_applegate]

@TheSimbaPikachu Todd Monken was right. Browns hurting Browns..

[NFL @NFL]

FINAL: The @Browns have won back-to-back games.

[Devon Applegate, PhD @devon_applegate]

HOW ABOUT THAT BROWNS WIN!!!

[Adam Schefter @AdamSchefter]

Browns quarterback Shedeur Sanders is the Week 3 NFLPA Community MVP for distributing 500 backpacks with supplies, and hosting a pizza and ice cream party for students at two East Cleveland schools. In honor of Sanders’ charitable efforts and this award, the NFLPA is making a $10,000 donation to his Legendary Impact Foundation.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

We are thrilled to share a major milestone for the Johns Hopkins Center for Psychedelic and Consciousness Research: @CeydaSayali, PhD, has received an R01 award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) — the first R01 awarded to an investigator at our Center.

The study will test a novel treatment approach for alcohol use disorder (AUD) combining psilocybin with personalized repetitive transcranial magnetic stimulation (rTMS). This is the first study to investigate this combination for AUD, with rTMS targets individualized using fMRI to identify each participant’s brain circuitry involved in regulating alcohol craving.

Using fMRI and TMS-EEG, the study will also examine how this combined intervention changes the neural mechanisms underlying craving, cognitive control, and treatment response.

By integrating psychedelic pharmacology, personalized brain stimulation, and multimodal neuroscience, this work aims to advance both treatment development and our understanding of how brain-based interventions can reduce problematic alcohol use.

Congratulations to Dr. Sayalı and the research team on this important achievement and exciting new direction for the Center.

[🧬Maxpein🧬 @maximumpain333]

Duncan Trussell recorded this conversation with his mother while she was facing terminal cancer.

What you’re hearing isn’t scripted. It isn’t performed. It’s a son sitting with his dying mother trying to hold onto every word before the words run out.
And she, the one facing the end, is the one doing the comforting.

That is what makes these conversations so extraordinary. Not the wisdom itself, as profound as it is. But who it’s coming from. A woman who had every reason to be consumed by her own fear choosing instead to spend what little time remained helping her son understand how to live without her.

These recordings became the heart of The Midnight Gospel. And I always go back to watch it again.

They remain some of the most honest conversations about death, love and what it means to be human ever put on screen…

[Adam Schefter @AdamSchefter]

Nick Chubb is returning to Cleveland to sign a one-day contract and retire as a Brown.

[Julie Holland, MD @BellevueDoc]

Psychedelic treatments for addiction recovery will save time and money
and will save lives.

[nature @Nature]

Just two doses of psilocybin administered before chemotherapy completely prevented mice from developing neuropathy

https://t.co/AMBn9D9J1Y

[Devon Applegate, PhD @devon_applegate]

@MikeLucasTV Nicely done. Congrats McNuggets!

[Devon Applegate, PhD @devon_applegate]

@KenCarman Just wait until you get a couple pints of daisy dips in you 👀 then it’s Super Bowl Super Browns!!

[Psychedelic Alpha @Psyched_Alpha]

This morning, LSD drug developer Definium Therapeutics announced that FDA has awarded its LSD candidate (DT120) Breakthrough Therapy designation for major depressive disorder.

The candidate had already received the designation for generalised anxiety disorder. Today’s news also means that DT120 is eligible for a Commissioner’s National Priority Voucher under the terms outlined in April’s Executive Order, which could catalyse its New Drug Application review, once submitted.

[Devon Applegate, PhD @devon_applegate]

@KenCarman You’re the man Kenny

[Devon Applegate, PhD @devon_applegate]

@923TheFan @NickWilsonSays @DaveandBusters @JPeterlin His shot may be good, but what about his Peterlin pass?

[Eric Topol @EricTopol]

More positive news on psychedelics: psilocybin doses before cancer chemotherapy protects neurons and helps prevent peripheral neuropathy in the experimental model @ScienceMagazine
https://t.co/4ft3ywxq7l
https://t.co/pR0qANxLX6

[Devon Applegate, PhD @devon_applegate]

Raheim Sanders stock rising 📈 @NickWilsonSays

[Ken Carman @KenCarman]

What a pleasure it was to see Nick Chubb play for the Browns. He’s beloved here forever.